← back to search

Patricia S. Steeg

National Cancer Institute ·
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Brain Metastases and Treatment, Mechanisms of cancer metastasis, Cancer Mechanisms and Therapy, and Nanoplatforms for cancer theranostics.
h-index
88
citations
33,415
works
593
NIH funding
primary concept
email

Recent publications

National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities
The Lancet Oncology 2023cited by 37position: middledoi
Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines
Cancer Research 2020cited by 126position: middledoi
Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other Organs
Molecular Cancer Research 2020cited by 34position: middledoi
52. BrMPANEL: A PUBLIC RESOURCE OF ORGANOTROPIC CELL LINES
Neuro-Oncology Advances 2020cited by 0position: middledoi
Brain metastases
Nature Reviews Disease Primers 2019cited by 1,019position: middledoi
Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis
Nature Cell Biology 2019cited by 429position: middledoi
The state of melanoma: challenges and opportunities
Pigment Cell & Melanoma Research 2016cited by 128position: middledoi
RETRACTED: FMN2 Makes Perinuclear Actin to Protect Nuclei during Confined Migration and Promote Metastasis
Cell 2016cited by 41position: middledoi
TMIC-18. ROLE OF MICROGLIA IN THE EARLY STEPS OF THE BRAIN METASTATIC CASCADE
Neuro-Oncology 2016cited by 0position: middledoi
OS7.1 Identification and characterization of brain metastasis initiating cells
Neuro-Oncology 2016cited by 0position: middledoi
Progress on Nme (NDP kinase/Nm23/Awd) gene family-related functions derived from animal model systems: studies on development, cardiovascular disease, and cancer metastasis exemplified
Naunyn-Schmiedeberg s Archives of Pharmacology 2015cited by 18position: middledoi
Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma
Clinical Cancer Research 2014cited by 199position: middledoi
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007
Breast Cancer Research and Treatment 2014cited by 17position: lastdoi
CNS Metastases in Breast Cancer: Old Challenge, New Frontiers
Clinical Cancer Research 2013cited by 1,284position: lastdoi
Roadblocks to translational advances on metastasis research
Nature Medicine 2013cited by 89position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Frank Winkler · TU Dresden3 papers (2016–2020)Matthias Osswald · German Cancer Research Center2 papers (2016–2016)Wolfgang Wick · Heidelberger Institut für Radioonkologie2 papers (2016–2016)Carey K. Anders · Virginia Commonwealth University2 papers (2019–2020)Anna S. Berghoff · Universitätszahnklinik Wien2 papers (2016–2016)Manmeet S. Ahluwalia · Memorial Hospital1 papers (2019–2019) · 1 papers (2020–2020) · 1 papers (2020–2020)Michael W. Davidson · National High Magnetic Field Laboratory1 papers (2016–2016)Johannes A. Hainfellner · Medical University of Vienna1 papers (2016–2016)David Lyden · Cornell University1 papers (2013–2013)Zena Werb · University of California, San Francisco1 papers (2013–2013)Nancy U. Lin · San Francisco Art Institute1 papers (2013–2013)Adrienne Boire · Kettering University1 papers (2020–2020)Gregory M. Alushin · Chan Zuckerberg Biohub San Francisco1 papers (2016–2016)Lisa A. Carey · University of North Carolina at Chapel Hill1 papers (2014–2014)Beatriz I Fernandez Gil · Center for Cancer Research1 papers (2016–2016)Achal S. Achrol · University of California, Santa Cruz1 papers (2019–2019)Joan Massagué · Duke Medical Center1 papers (2020–2020)Manuel Valiente · Spanish National Cancer Research Centre1 papers (2020–2020)